Rite Aid (NYSE:RAD) reported what seemed on the surface to be a not-so-great quarter -- earnings per share dropped by half year-over-year, even though revenue increased slightly.

But health care analysts Michael Douglass and David Williamson found some intriguing opportunities for the company as it continues its now-famous turnaround. Management continues to execute on critical potential growth drivers -- opportunities the company needs if it's going to continue its meteoric rise.

In the video below, they lay out three key things Rite Aid must continue to execute on as it seeks to catch up to CVS Caremark (NYSE:CVS).

David Williamson has no position in any stocks mentioned. Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends CVS Caremark and McKesson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.